Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis

This review (17 RCTs; n=83 617) found robust evidence that Omega-3 supplementation as ≤1 1g capsule/day was not associated with CVD outcomes and weaker evidence that higher-dose supplementation may be associated with a reduction in cardiac death, sudden death and stroke.